Sensus HealthcareSRTS +10.58%76 PB Ratio is 1.09 as of Jun. 24, 2026, which is 63% below its 10-year median of 2.92. GuruFocus rates SRTS with a GF Score™ of 76/100 and a GF Value™ of $2.85 (Fairly Valued). The stock has 4 warning signs investors should review. Among 787 Medical Devices & Instruments companies, Sensus Healthcare ranks better than 79.16% on this metric.
Sensus Healthcare Inc stock PB Ratio (=0.99) is close to 2-year low of 0.98.
The historical rank and industry rank for Sensus Healthcare's PB Ratio or its related term are showing as below:
SRTS'
s PB Ratio Range Over the Past 10 Years
Min: 0.7 Med: 2.92 Max: 10.65
Current: 1.09
During the past 13 years, Sensus Healthcare's highest PB Ratio was 10.65. The lowest was 0.70. And the median was 2.92.
SRTS's PB Ratio is ranked better than 79.16% of 787
companies
in the Medical Devices & Instruments industry
Industry Median: 2.04
vs SRTS: 1.09
During the past 12 months, Sensus Healthcare's average Book Value Per Share Growth Rate was -14.20% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was -0.10% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 19.90% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was 18.50% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Sensus Healthcare was 55.50% per year. The lowest was -1.60% per year. And the median was 20.00% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Sensus Healthcare PB Ratio Related Terms
Sensus Healthcare PB Ratio Historical Data
* Premium members only.
The historical data trend for Sensus Healthcare's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Sensus Healthcare's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sensus Healthcare PB Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Sensus Healthcare's PB Ratio distribution charts can be found below:
* The bar in red indicates where Sensus Healthcare's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Sensus Healthcare (SRTS) has a PB Ratio of 1.09 as of Jun. 24, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Sensus Healthcare and its competitors. This is 63% below median its historical median of 2.92. Over the past decade, Sensus Healthcare's PB Ratio has ranged from 0.70 to 10.65. According to the industry distribution chart, Sensus Healthcare ranks #164 out of 787 companies in the Medical Devices & Instruments industry, placing it in the top 20.8%.
Is Sensus Healthcare's PB Ratio too high?
Sensus Healthcare's current PB Ratio of 1.09 is 63% below median its 10-year median of 2.92. Over the past 10 years, this metric has ranged from a low of 0.70 to a high of 10.65. The Medical Devices & Instruments industry median PB Ratio is 2.04. Sensus Healthcare's value of 1.09 is 46.6% below this industry median. Based on the distribution chart, Sensus Healthcare ranks #164 out of 787 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Sensus Healthcare has a GF Score™ of 76/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Sensus Healthcare's PB Ratio compare to ELUT and COCH?
According to the Medical Devices & Instruments industry distribution chart, Sensus Healthcare ranks #164 out of 787 companies for PB Ratio. This places Sensus Healthcare in the top 21% of its industry — outperforming the majority of peers. The industry median PB Ratio is 2.04. Sensus Healthcare's value of 1.09 is 46.6% below this benchmark. Historically, Sensus Healthcare's own PB Ratio has ranged from 0.70 to 10.65 over the past decade. While the company's 10-year median is 2.92 vs. the industry median of 2.04, Sensus Healthcare has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Medical Devices & Instruments company?
The median PB Ratio among Medical Devices & Instruments companies is 2.04, based on 787 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sensus Healthcare's current PB Ratio of 1.09 is 46.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Sensus Healthcare and its competitors. For the Medical Devices & Instruments industry, the median PB Ratio is 2.04 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sensus Healthcare's current PB Ratio is 1.09, which is 63% below median its own 10-year median of 2.92. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sensus Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Sensus Healthcare (SRTS) is currently considered Fairly Valued. The stock's GF Value™ is $2.85, compared to a current price of $3.02 — trading 6% above its estimated fair value. The current PB Ratio is 1.09, which is 63% below median its 10-year median of 2.92 and 46.6% below the Medical Devices & Instruments industry median of 2.04. Sensus Healthcare's overall GF Score™ is 76/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Sensus Healthcare (SRTS), the current PB Ratio is 1.09 as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sensus Healthcare (SRTS) Overvalued in 2026?
Based on GuruFocus' analysis, Sensus Healthcare stock appears to be overvalued.
The current stock price of $3.02 is trading 6% above its estimated GF Value™ of $2.85.
GuruFocus considers Sensus Healthcare to be Fairly Valued.
Key valuation signals for SRTS:
PB Ratio: 1.09 (63% below median its 10-year median of 2.92)
GF Value™: $2.85 vs. price of $3.02 (6% above fair value)
Industry Position: 46.6% below the Medical Devices & Instruments median (#164 of 787)
No single metric tells the full story. See the SRTS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.
76GF Score
Get the complete analysis for SRTS
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SRTS has been successfully added to your 
